img

Global Oncology Drug Discovery Services Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Oncology Drug Discovery Services Market Research Report 2024

The Oncology Drug Discovery Service is dedicated to oncology research, providing high-quality, timely and cost-effective oncology drug discovery and accelerating the development of the immunooncology product portfolio to develop new drugs that benefit human health.
According to MRAResearch’s new survey, global Oncology Drug Discovery Services market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Oncology Drug Discovery Services market research.
Key companies engaged in the Oncology Drug Discovery Services industry include Charles River, Evotec, GE Healthcare Life Sciences, GenScript, Horizon Discovery, TCG Lifesciences, Zumutor, ChemPartner and Aquila BioMedical, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Oncology Drug Discovery Services were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Oncology Drug Discovery Services market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Oncology Drug Discovery Services market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Charles River
Evotec
GE Healthcare Life Sciences
GenScript
Horizon Discovery
TCG Lifesciences
Zumutor
ChemPartner
Aquila BioMedical
Onconova
Vichem Chemie
GVK Biosciences
NuChem Therapeutics
Syncom
Envigo
DiverChim
Aurora
HD Biosciences
WuXi AppTec
Segment by Type
Identification Service
Authentication Service
Hit-to-lead and Lead Optimization Services
Others

Segment by Application


Research Institutes
Pharmaceutical Companies
Biotechnology Companies
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Oncology Drug Discovery Services report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oncology Drug Discovery Services Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Identification Service
1.2.3 Authentication Service
1.2.4 Hit-to-lead and Lead Optimization Services
1.2.5 Others
1.3 Market by Application
1.3.1 Global Oncology Drug Discovery Services Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Research Institutes
1.3.3 Pharmaceutical Companies
1.3.4 Biotechnology Companies
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oncology Drug Discovery Services Market Perspective (2018-2033)
2.2 Oncology Drug Discovery Services Growth Trends by Region
2.2.1 Global Oncology Drug Discovery Services Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Oncology Drug Discovery Services Historic Market Size by Region (2018-2023)
2.2.3 Oncology Drug Discovery Services Forecasted Market Size by Region (2024-2033)
2.3 Oncology Drug Discovery Services Market Dynamics
2.3.1 Oncology Drug Discovery Services Industry Trends
2.3.2 Oncology Drug Discovery Services Market Drivers
2.3.3 Oncology Drug Discovery Services Market Challenges
2.3.4 Oncology Drug Discovery Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oncology Drug Discovery Services Players by Revenue
3.1.1 Global Top Oncology Drug Discovery Services Players by Revenue (2018-2023)
3.1.2 Global Oncology Drug Discovery Services Revenue Market Share by Players (2018-2023)
3.2 Global Oncology Drug Discovery Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Oncology Drug Discovery Services Revenue
3.4 Global Oncology Drug Discovery Services Market Concentration Ratio
3.4.1 Global Oncology Drug Discovery Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oncology Drug Discovery Services Revenue in 2022
3.5 Oncology Drug Discovery Services Key Players Head office and Area Served
3.6 Key Players Oncology Drug Discovery Services Product Solution and Service
3.7 Date of Enter into Oncology Drug Discovery Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oncology Drug Discovery Services Breakdown Data by Type
4.1 Global Oncology Drug Discovery Services Historic Market Size by Type (2018-2023)
4.2 Global Oncology Drug Discovery Services Forecasted Market Size by Type (2024-2033)
5 Oncology Drug Discovery Services Breakdown Data by Application
5.1 Global Oncology Drug Discovery Services Historic Market Size by Application (2018-2023)
5.2 Global Oncology Drug Discovery Services Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Oncology Drug Discovery Services Market Size (2018-2033)
6.2 North America Oncology Drug Discovery Services Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Oncology Drug Discovery Services Market Size by Country (2018-2023)
6.4 North America Oncology Drug Discovery Services Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oncology Drug Discovery Services Market Size (2018-2033)
7.2 Europe Oncology Drug Discovery Services Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Oncology Drug Discovery Services Market Size by Country (2018-2023)
7.4 Europe Oncology Drug Discovery Services Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oncology Drug Discovery Services Market Size (2018-2033)
8.2 Asia-Pacific Oncology Drug Discovery Services Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Oncology Drug Discovery Services Market Size by Region (2018-2023)
8.4 Asia-Pacific Oncology Drug Discovery Services Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oncology Drug Discovery Services Market Size (2018-2033)
9.2 Latin America Oncology Drug Discovery Services Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Oncology Drug Discovery Services Market Size by Country (2018-2023)
9.4 Latin America Oncology Drug Discovery Services Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oncology Drug Discovery Services Market Size (2018-2033)
10.2 Middle East & Africa Oncology Drug Discovery Services Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Oncology Drug Discovery Services Market Size by Country (2018-2023)
10.4 Middle East & Africa Oncology Drug Discovery Services Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Charles River
11.1.1 Charles River Company Detail
11.1.2 Charles River Business Overview
11.1.3 Charles River Oncology Drug Discovery Services Introduction
11.1.4 Charles River Revenue in Oncology Drug Discovery Services Business (2018-2023)
11.1.5 Charles River Recent Development
11.2 Evotec
11.2.1 Evotec Company Detail
11.2.2 Evotec Business Overview
11.2.3 Evotec Oncology Drug Discovery Services Introduction
11.2.4 Evotec Revenue in Oncology Drug Discovery Services Business (2018-2023)
11.2.5 Evotec Recent Development
11.3 GE Healthcare Life Sciences
11.3.1 GE Healthcare Life Sciences Company Detail
11.3.2 GE Healthcare Life Sciences Business Overview
11.3.3 GE Healthcare Life Sciences Oncology Drug Discovery Services Introduction
11.3.4 GE Healthcare Life Sciences Revenue in Oncology Drug Discovery Services Business (2018-2023)
11.3.5 GE Healthcare Life Sciences Recent Development
11.4 GenScript
11.4.1 GenScript Company Detail
11.4.2 GenScript Business Overview
11.4.3 GenScript Oncology Drug Discovery Services Introduction
11.4.4 GenScript Revenue in Oncology Drug Discovery Services Business (2018-2023)
11.4.5 GenScript Recent Development
11.5 Horizon Discovery
11.5.1 Horizon Discovery Company Detail
11.5.2 Horizon Discovery Business Overview
11.5.3 Horizon Discovery Oncology Drug Discovery Services Introduction
11.5.4 Horizon Discovery Revenue in Oncology Drug Discovery Services Business (2018-2023)
11.5.5 Horizon Discovery Recent Development
11.6 TCG Lifesciences
11.6.1 TCG Lifesciences Company Detail
11.6.2 TCG Lifesciences Business Overview
11.6.3 TCG Lifesciences Oncology Drug Discovery Services Introduction
11.6.4 TCG Lifesciences Revenue in Oncology Drug Discovery Services Business (2018-2023)
11.6.5 TCG Lifesciences Recent Development
11.7 Zumutor
11.7.1 Zumutor Company Detail
11.7.2 Zumutor Business Overview
11.7.3 Zumutor Oncology Drug Discovery Services Introduction
11.7.4 Zumutor Revenue in Oncology Drug Discovery Services Business (2018-2023)
11.7.5 Zumutor Recent Development
11.8 ChemPartner
11.8.1 ChemPartner Company Detail
11.8.2 ChemPartner Business Overview
11.8.3 ChemPartner Oncology Drug Discovery Services Introduction
11.8.4 ChemPartner Revenue in Oncology Drug Discovery Services Business (2018-2023)
11.8.5 ChemPartner Recent Development
11.9 Aquila BioMedical
11.9.1 Aquila BioMedical Company Detail
11.9.2 Aquila BioMedical Business Overview
11.9.3 Aquila BioMedical Oncology Drug Discovery Services Introduction
11.9.4 Aquila BioMedical Revenue in Oncology Drug Discovery Services Business (2018-2023)
11.9.5 Aquila BioMedical Recent Development
11.10 Onconova
11.10.1 Onconova Company Detail
11.10.2 Onconova Business Overview
11.10.3 Onconova Oncology Drug Discovery Services Introduction
11.10.4 Onconova Revenue in Oncology Drug Discovery Services Business (2018-2023)
11.10.5 Onconova Recent Development
11.11 Vichem Chemie
11.11.1 Vichem Chemie Company Detail
11.11.2 Vichem Chemie Business Overview
11.11.3 Vichem Chemie Oncology Drug Discovery Services Introduction
11.11.4 Vichem Chemie Revenue in Oncology Drug Discovery Services Business (2018-2023)
11.11.5 Vichem Chemie Recent Development
11.12 GVK Biosciences
11.12.1 GVK Biosciences Company Detail
11.12.2 GVK Biosciences Business Overview
11.12.3 GVK Biosciences Oncology Drug Discovery Services Introduction
11.12.4 GVK Biosciences Revenue in Oncology Drug Discovery Services Business (2018-2023)
11.12.5 GVK Biosciences Recent Development
11.13 NuChem Therapeutics
11.13.1 NuChem Therapeutics Company Detail
11.13.2 NuChem Therapeutics Business Overview
11.13.3 NuChem Therapeutics Oncology Drug Discovery Services Introduction
11.13.4 NuChem Therapeutics Revenue in Oncology Drug Discovery Services Business (2018-2023)
11.13.5 NuChem Therapeutics Recent Development
11.14 Syncom
11.14.1 Syncom Company Detail
11.14.2 Syncom Business Overview
11.14.3 Syncom Oncology Drug Discovery Services Introduction
11.14.4 Syncom Revenue in Oncology Drug Discovery Services Business (2018-2023)
11.14.5 Syncom Recent Development
11.15 Envigo
11.15.1 Envigo Company Detail
11.15.2 Envigo Business Overview
11.15.3 Envigo Oncology Drug Discovery Services Introduction
11.15.4 Envigo Revenue in Oncology Drug Discovery Services Business (2018-2023)
11.15.5 Envigo Recent Development
11.16 DiverChim
11.16.1 DiverChim Company Detail
11.16.2 DiverChim Business Overview
11.16.3 DiverChim Oncology Drug Discovery Services Introduction
11.16.4 DiverChim Revenue in Oncology Drug Discovery Services Business (2018-2023)
11.16.5 DiverChim Recent Development
11.17 Aurora
11.17.1 Aurora Company Detail
11.17.2 Aurora Business Overview
11.17.3 Aurora Oncology Drug Discovery Services Introduction
11.17.4 Aurora Revenue in Oncology Drug Discovery Services Business (2018-2023)
11.17.5 Aurora Recent Development
11.18 HD Biosciences
11.18.1 HD Biosciences Company Detail
11.18.2 HD Biosciences Business Overview
11.18.3 HD Biosciences Oncology Drug Discovery Services Introduction
11.18.4 HD Biosciences Revenue in Oncology Drug Discovery Services Business (2018-2023)
11.18.5 HD Biosciences Recent Development
11.19 WuXi AppTec
11.19.1 WuXi AppTec Company Detail
11.19.2 WuXi AppTec Business Overview
11.19.3 WuXi AppTec Oncology Drug Discovery Services Introduction
11.19.4 WuXi AppTec Revenue in Oncology Drug Discovery Services Business (2018-2023)
11.19.5 WuXi AppTec Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Oncology Drug Discovery Services Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Identification Service
Table 3. Key Players of Authentication Service
Table 4. Key Players of Hit-to-lead and Lead Optimization Services
Table 5. Key Players of Others
Table 6. Global Oncology Drug Discovery Services Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Oncology Drug Discovery Services Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Oncology Drug Discovery Services Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Oncology Drug Discovery Services Market Share by Region (2018-2023)
Table 10. Global Oncology Drug Discovery Services Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Oncology Drug Discovery Services Market Share by Region (2024-2033)
Table 12. Oncology Drug Discovery Services Market Trends
Table 13. Oncology Drug Discovery Services Market Drivers
Table 14. Oncology Drug Discovery Services Market Challenges
Table 15. Oncology Drug Discovery Services Market Restraints
Table 16. Global Oncology Drug Discovery Services Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Oncology Drug Discovery Services Market Share by Players (2018-2023)
Table 18. Global Top Oncology Drug Discovery Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Drug Discovery Services as of 2022)
Table 19. Ranking of Global Top Oncology Drug Discovery Services Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Oncology Drug Discovery Services Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Oncology Drug Discovery Services Product Solution and Service
Table 23. Date of Enter into Oncology Drug Discovery Services Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Oncology Drug Discovery Services Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Oncology Drug Discovery Services Revenue Market Share by Type (2018-2023)
Table 27. Global Oncology Drug Discovery Services Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Oncology Drug Discovery Services Revenue Market Share by Type (2024-2033)
Table 29. Global Oncology Drug Discovery Services Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Oncology Drug Discovery Services Revenue Market Share by Application (2018-2023)
Table 31. Global Oncology Drug Discovery Services Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Oncology Drug Discovery Services Revenue Market Share by Application (2024-2033)
Table 33. North America Oncology Drug Discovery Services Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 34. North America Oncology Drug Discovery Services Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Oncology Drug Discovery Services Market Size by Country (2024-2033) & (US$ Million)
Table 36. Europe Oncology Drug Discovery Services Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. Europe Oncology Drug Discovery Services Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Oncology Drug Discovery Services Market Size by Country (2024-2033) & (US$ Million)
Table 39. Asia-Pacific Oncology Drug Discovery Services Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 40. Asia-Pacific Oncology Drug Discovery Services Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Oncology Drug Discovery Services Market Size by Region (2024-2033) & (US$ Million)
Table 42. Latin America Oncology Drug Discovery Services Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Latin America Oncology Drug Discovery Services Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Oncology Drug Discovery Services Market Size by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa Oncology Drug Discovery Services Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Middle East & Africa Oncology Drug Discovery Services Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Oncology Drug Discovery Services Market Size by Country (2024-2033) & (US$ Million)
Table 48. Charles River Company Detail
Table 49. Charles River Business Overview
Table 50. Charles River Oncology Drug Discovery Services Product
Table 51. Charles River Revenue in Oncology Drug Discovery Services Business (2018-2023) & (US$ Million)
Table 52. Charles River Recent Development
Table 53. Evotec Company Detail
Table 54. Evotec Business Overview
Table 55. Evotec Oncology Drug Discovery Services Product
Table 56. Evotec Revenue in Oncology Drug Discovery Services Business (2018-2023) & (US$ Million)
Table 57. Evotec Recent Development
Table 58. GE Healthcare Life Sciences Company Detail
Table 59. GE Healthcare Life Sciences Business Overview
Table 60. GE Healthcare Life Sciences Oncology Drug Discovery Services Product
Table 61. GE Healthcare Life Sciences Revenue in Oncology Drug Discovery Services Business (2018-2023) & (US$ Million)
Table 62. GE Healthcare Life Sciences Recent Development
Table 63. GenScript Company Detail
Table 64. GenScript Business Overview
Table 65. GenScript Oncology Drug Discovery Services Product
Table 66. GenScript Revenue in Oncology Drug Discovery Services Business (2018-2023) & (US$ Million)
Table 67. GenScript Recent Development
Table 68. Horizon Discovery Company Detail
Table 69. Horizon Discovery Business Overview
Table 70. Horizon Discovery Oncology Drug Discovery Services Product
Table 71. Horizon Discovery Revenue in Oncology Drug Discovery Services Business (2018-2023) & (US$ Million)
Table 72. Horizon Discovery Recent Development
Table 73. TCG Lifesciences Company Detail
Table 74. TCG Lifesciences Business Overview
Table 75. TCG Lifesciences Oncology Drug Discovery Services Product
Table 76. TCG Lifesciences Revenue in Oncology Drug Discovery Services Business (2018-2023) & (US$ Million)
Table 77. TCG Lifesciences Recent Development
Table 78. Zumutor Company Detail
Table 79. Zumutor Business Overview
Table 80. Zumutor Oncology Drug Discovery Services Product
Table 81. Zumutor Revenue in Oncology Drug Discovery Services Business (2018-2023) & (US$ Million)
Table 82. Zumutor Recent Development
Table 83. ChemPartner Company Detail
Table 84. ChemPartner Business Overview
Table 85. ChemPartner Oncology Drug Discovery Services Product
Table 86. ChemPartner Revenue in Oncology Drug Discovery Services Business (2018-2023) & (US$ Million)
Table 87. ChemPartner Recent Development
Table 88. Aquila BioMedical Company Detail
Table 89. Aquila BioMedical Business Overview
Table 90. Aquila BioMedical Oncology Drug Discovery Services Product
Table 91. Aquila BioMedical Revenue in Oncology Drug Discovery Services Business (2018-2023) & (US$ Million)
Table 92. Aquila BioMedical Recent Development
Table 93. Onconova Company Detail
Table 94. Onconova Business Overview
Table 95. Onconova Oncology Drug Discovery Services Product
Table 96. Onconova Revenue in Oncology Drug Discovery Services Business (2018-2023) & (US$ Million)
Table 97. Onconova Recent Development
Table 98. Vichem Chemie Company Detail
Table 99. Vichem Chemie Business Overview
Table 100. Vichem Chemie Oncology Drug Discovery Services Product
Table 101. Vichem Chemie Revenue in Oncology Drug Discovery Services Business (2018-2023) & (US$ Million)
Table 102. Vichem Chemie Recent Development
Table 103. GVK Biosciences Company Detail
Table 104. GVK Biosciences Business Overview
Table 105. GVK Biosciences Oncology Drug Discovery Services Product
Table 106. GVK Biosciences Revenue in Oncology Drug Discovery Services Business (2018-2023) & (US$ Million)
Table 107. GVK Biosciences Recent Development
Table 108. NuChem Therapeutics Company Detail
Table 109. NuChem Therapeutics Business Overview
Table 110. NuChem Therapeutics Oncology Drug Discovery Services Product
Table 111. NuChem Therapeutics Revenue in Oncology Drug Discovery Services Business (2018-2023) & (US$ Million)
Table 112. NuChem Therapeutics Recent Development
Table 113. Syncom Company Detail
Table 114. Syncom Business Overview
Table 115. Syncom Oncology Drug Discovery Services Product
Table 116. Syncom Revenue in Oncology Drug Discovery Services Business (2018-2023) & (US$ Million)
Table 117. Syncom Recent Development
Table 118. Envigo Company Detail
Table 119. Envigo Business Overview
Table 120. Envigo Oncology Drug Discovery Services Product
Table 121. Envigo Revenue in Oncology Drug Discovery Services Business (2018-2023) & (US$ Million)
Table 122. Envigo Recent Development
Table 123. DiverChim Company Detail
Table 124. DiverChim Business Overview
Table 125. DiverChim Oncology Drug Discovery Services Product
Table 126. DiverChim Revenue in Oncology Drug Discovery Services Business (2018-2023) & (US$ Million)
Table 127. DiverChim Recent Development
Table 128. Aurora Company Detail
Table 129. Aurora Business Overview
Table 130. Aurora Oncology Drug Discovery Services Product
Table 131. Aurora Revenue in Oncology Drug Discovery Services Business (2018-2023) & (US$ Million)
Table 132. Aurora Recent Development
Table 133. HD Biosciences Company Detail
Table 134. HD Biosciences Business Overview
Table 135. HD Biosciences Oncology Drug Discovery Services Product
Table 136. HD Biosciences Revenue in Oncology Drug Discovery Services Business (2018-2023) & (US$ Million)
Table 137. HD Biosciences Recent Development
Table 138. WuXi AppTec Company Detail
Table 139. WuXi AppTec Business Overview
Table 140. WuXi AppTec Oncology Drug Discovery Services Product
Table 141. WuXi AppTec Revenue in Oncology Drug Discovery Services Business (2018-2023) & (US$ Million)
Table 142. WuXi AppTec Recent Development
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oncology Drug Discovery Services Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Oncology Drug Discovery Services Market Share by Type: 2022 VS 2033
Figure 3. Identification Service Features
Figure 4. Authentication Service Features
Figure 5. Hit-to-lead and Lead Optimization Services Features
Figure 6. Others Features
Figure 7. Global Oncology Drug Discovery Services Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 8. Global Oncology Drug Discovery Services Market Share by Application: 2022 VS 2033
Figure 9. Research Institutes Case Studies
Figure 10. Pharmaceutical Companies Case Studies
Figure 11. Biotechnology Companies Case Studies
Figure 12. Others Case Studies
Figure 13. Oncology Drug Discovery Services Report Years Considered
Figure 14. Global Oncology Drug Discovery Services Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 15. Global Oncology Drug Discovery Services Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 16. Global Oncology Drug Discovery Services Market Share by Region: 2022 VS 2033
Figure 17. Global Oncology Drug Discovery Services Market Share by Players in 2022
Figure 18. Global Top Oncology Drug Discovery Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Drug Discovery Services as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Oncology Drug Discovery Services Revenue in 2022
Figure 20. North America Oncology Drug Discovery Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. North America Oncology Drug Discovery Services Market Share by Country (2018-2033)
Figure 22. United States Oncology Drug Discovery Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada Oncology Drug Discovery Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Oncology Drug Discovery Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Oncology Drug Discovery Services Market Share by Country (2018-2033)
Figure 26. Germany Oncology Drug Discovery Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. France Oncology Drug Discovery Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. U.K. Oncology Drug Discovery Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Italy Oncology Drug Discovery Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Russia Oncology Drug Discovery Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Nordic Countries Oncology Drug Discovery Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Oncology Drug Discovery Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific Oncology Drug Discovery Services Market Share by Region (2018-2033)
Figure 34. China Oncology Drug Discovery Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Japan Oncology Drug Discovery Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. South Korea Oncology Drug Discovery Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Southeast Asia Oncology Drug Discovery Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. India Oncology Drug Discovery Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Australia Oncology Drug Discovery Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Oncology Drug Discovery Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America Oncology Drug Discovery Services Market Share by Country (2018-2033)
Figure 42. Mexico Oncology Drug Discovery Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Brazil Oncology Drug Discovery Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Oncology Drug Discovery Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa Oncology Drug Discovery Services Market Share by Country (2018-2033)
Figure 46. Turkey Oncology Drug Discovery Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Saudi Arabia Oncology Drug Discovery Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Charles River Revenue Growth Rate in Oncology Drug Discovery Services Business (2018-2023)
Figure 49. Evotec Revenue Growth Rate in Oncology Drug Discovery Services Business (2018-2023)
Figure 50. GE Healthcare Life Sciences Revenue Growth Rate in Oncology Drug Discovery Services Business (2018-2023)
Figure 51. GenScript Revenue Growth Rate in Oncology Drug Discovery Services Business (2018-2023)
Figure 52. Horizon Discovery Revenue Growth Rate in Oncology Drug Discovery Services Business (2018-2023)
Figure 53. TCG Lifesciences Revenue Growth Rate in Oncology Drug Discovery Services Business (2018-2023)
Figure 54. Zumutor Revenue Growth Rate in Oncology Drug Discovery Services Business (2018-2023)
Figure 55. ChemPartner Revenue Growth Rate in Oncology Drug Discovery Services Business (2018-2023)
Figure 56. Aquila BioMedical Revenue Growth Rate in Oncology Drug Discovery Services Business (2018-2023)
Figure 57. Onconova Revenue Growth Rate in Oncology Drug Discovery Services Business (2018-2023)
Figure 58. Vichem Chemie Revenue Growth Rate in Oncology Drug Discovery Services Business (2018-2023)
Figure 59. GVK Biosciences Revenue Growth Rate in Oncology Drug Discovery Services Business (2018-2023)
Figure 60. NuChem Therapeutics Revenue Growth Rate in Oncology Drug Discovery Services Business (2018-2023)
Figure 61. Syncom Revenue Growth Rate in Oncology Drug Discovery Services Business (2018-2023)
Figure 62. Envigo Revenue Growth Rate in Oncology Drug Discovery Services Business (2018-2023)
Figure 63. DiverChim Revenue Growth Rate in Oncology Drug Discovery Services Business (2018-2023)
Figure 64. Aurora Revenue Growth Rate in Oncology Drug Discovery Services Business (2018-2023)
Figure 65. HD Biosciences Revenue Growth Rate in Oncology Drug Discovery Services Business (2018-2023)
Figure 66. WuXi AppTec Revenue Growth Rate in Oncology Drug Discovery Services Business (2018-2023)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed